Furthermore, inflammation induces the accumulation of immune cells such as “antitumor” M1 macrophages (producing ROSs, IL-1β, TNFα, IL-6, and IL-12) in the tumor microenvironment, which are then reprogrammed by the tumor cells to a M2 phenotype. The gene discussed is IL1B; the disease is neoplasm.